T 1131/18 (Combination of Pimobendan and Benazepril/ ELANCO) of 19.10.2021
- European Case Law Identifier
- ECLI:EP:BA:2021:T113118.20211019
- Date of decision
- 19 October 2021
- Case number
- T 1131/18
- Online on
- 7 February 2022
- Petition for review of
- -
- Application number
- 12813324.6
- Language of proceedings
- English
- Distribution
- No distribution (D)
- Download
- Decision in English
- OJ versions
- No OJ links found
- Other decisions for this case
- -
- Abstracts for this decision
- -
- Application title
- NEW COMBINATION
- Applicant name
- Elanco Tiergesundheit AG
- Opponent name
- Boehringer Ingelheim Vetmedica GmbH
- Board
- 3.3.07
- Headnote
- -
- Relevant legal provisions
- European Patent Convention R 103(1)(a)Rules of procedure of the Boards of Appeal Art 12(4)Rules of procedure of the Boards of Appeal 2020 Art 013(2)European Patent Convention Art 123(2)European Patent Convention Art 83European Patent Convention Art 84European Patent Convention Art 54European Patent Convention Art 56
- Keywords
- Violation of procedure (No) - Reimbursement of the appeal fees (No)
Admission of documents (Yes)
Admission of the main request (Yes)
Main request - Extension beyond the original content (No)
Main request - Sufficiency of disclosure (Yes)
Main request - Clarity (Yes)
Main request - Novelty (Yes)
Main request - Inventive step (Yes) - Catchword
- -
- Cited cases
- -
- Citing cases
- -
Order
For these reasons it is decided that:
1. The decision under appeal is set aside.
2. The case is remitted to the opposition division with the order to maintain the patent on the basis of the main request filed by letter dated 16 January 2020.
3. The request to reimburse the appeal fee is rejected.